Despite endorsed and exponential research to improve diagnostic and therapeutic
strategies, efforts have not yet converted into a better prospect for patients infected with the …

Intravenous immunoglobulin (IVIg) therapy has been suggested as a potential treatment
option for hospitalised COVID‐19 patients. The aim of this systematic review and meta …

Background The benefit of IVIG (Intravenous Immunoglobulin) therapy for COVID-19
remains controversial. We performed a meta-analysis to investigate the efficacy of IVIG …

Background and purpose Myasthenia gravis (MG) patients could be a vulnerable group in
the pandemic era of coronavirus 2019 (COVID‐19) mainly due to respiratory muscle …

Пандемия коронавирусной болезни 2019 (coronavirus disease, COVID-19),
этиологически связанной с вирусом SARS-CoV-2 (severe acute respiratory syndrome …

Background Currently, there is no specific drug for the treatment of coronavirus disease
2019 (COVID-19). Therapeutic benefits of intravenous immunoglobulin (IVIG) have been …

COVID-19 is a viral infection caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) that killed a large number of patients around the world. A hyperinflammatory …

Intravenous immunoglobulin (IVIG) is used as an immunomodulatory agent in the treatment
of various autoimmune/inflammatory diseases although its mechanism of action remains …

Abstract The coronavirus disease‐19 (COVID‐19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) challenged globally with its morbidity …

The coronavirus 2019 pandemic (coronavirus disease, COVID-19), etiologically related to
the SARS-CoV-2 virus (severe acute respiratory syndrome coronavirus-2), has once again …